Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)
- PMID: 17327285
- PMCID: PMC2740877
- DOI: 10.1136/jmg.2007.048991
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)
Abstract
Lynch syndrome (hereditary non-polyposis colorectal cancer) is characterised by the development of colorectal cancer, endometrial cancer and various other cancers, and is caused by a mutation in one of the mismatch repair genes: MLH1, MSH2, MSH6 or PMS2. The discovery of these genes, 15 years ago, has led to the identification of large numbers of affected families. In April 2006, a workshop was organised by a group of European experts in hereditary gastrointestinal cancer (the Mallorca-group), aiming to establish guidelines for the clinical management of Lynch syndrome. 21 experts from nine European countries participated in this workshop. Prior to the meeting, various participants prepared the key management issues of debate according to the latest publications. A systematic literature search using Pubmed and the Cochrane Database of Systematic Reviews reference lists of retrieved articles and manual searches of relevant articles was performed. During the workshop, all recommendations were discussed in detail. Because most of the studies that form the basis for the recommendations were descriptive and/or retrospective in nature, many of them were based on expert opinion. The guidelines described in this manuscript may be helpful for the appropriate management of families with Lynch syndrome. Prospective controlled studies should be undertaken to improve further the care of these families.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts.Gut. 2013 Jun;62(6):812-23. doi: 10.1136/gutjnl-2012-304356. Epub 2013 Feb 13. Gut. 2013. PMID: 23408351 Free PMC article.
-
Guidelines for the clinical management of familial adenomatous polyposis (FAP).Gut. 2008 May;57(5):704-13. doi: 10.1136/gut.2007.136127. Epub 2008 Jan 14. Gut. 2008. PMID: 18194984
-
Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.JAMA. 2006 Sep 27;296(12):1507-17. doi: 10.1001/jama.296.12.1507. JAMA. 2006. PMID: 17003399 Review.
-
Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer).Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:113-26. doi: 10.1111/j.1365-2036.2007.03479.x. Aliment Pharmacol Ther. 2007. PMID: 18081655 Review.
-
Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw. 2016 Aug;14(8):1010-30. doi: 10.6004/jnccn.2016.0108. J Natl Compr Canc Netw. 2016. PMID: 27496117
Cited by
-
Aberrant splicing caused by a MLH1 splice donor site mutation found in a young Japanese patient with Lynch syndrome.Fam Cancer. 2012 Dec;11(4):559-64. doi: 10.1007/s10689-012-9547-1. Fam Cancer. 2012. PMID: 22766992
-
Clinical management of hereditary colorectal cancer syndromes.Nat Rev Gastroenterol Hepatol. 2015 Feb;12(2):88-97. doi: 10.1038/nrgastro.2014.229. Epub 2015 Jan 13. Nat Rev Gastroenterol Hepatol. 2015. PMID: 25582351 Review.
-
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium.Hered Cancer Clin Pract. 2022 Oct 1;20(1):36. doi: 10.1186/s13053-022-00241-1. Hered Cancer Clin Pract. 2022. PMID: 36182917 Free PMC article.
-
Microsatellite instability is biased in Amsterdam II-defined Lynch-related cancer cases with family history but is rare in other cancers: a summary of 1000 analyses.BMC Cancer. 2022 Jan 17;22(1):73. doi: 10.1186/s12885-022-09172-5. BMC Cancer. 2022. PMID: 35039004 Free PMC article.
-
Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the colon.Int J Colorectal Dis. 2012 Mar;27(3):371-9. doi: 10.1007/s00384-011-1343-0. Epub 2011 Nov 4. Int J Colorectal Dis. 2012. PMID: 22052041
References
-
- Lynch H T, Chapelle de la A. Hereditary colorectal cancer. N Engl J Med 2003348919–932. - PubMed
-
- Al Tassan N, Chmiel N H, Maynard J, Fleming N, Livingston A L, Williams G T, Hodges A K, Davies D R, David S S, Sampson J R, Cheadle J P. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet 200230227–232. - PubMed
-
- Vasen H F, Wijnen J T, Menko F H, Kleibeuker J H, Taal B G, Griffioen G, Nagengast F M, Meijers‐Heijboer E H, Bertario L, Varesco L, Bisgaard M L, Mohr J, Fodde R, Khan P M. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 19961101020–1027. - PubMed
-
- Dunlop M G, Farrington S M, Carothers A D, Wyllie A H, Sharp L, Burn J, Liu B, Kinzler K W, Vogelstein B. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 19976105–110. - PubMed
-
- Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen L A, de la Chapelle A, Peltomaki P, Mecklin J P, Jarvinen H J. Cancer risk in mutation carriers of DNA‐mismatch‐repair genes. Int J Cancer 199981214–218. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous